Pharmaceutical Technology
MARCH 14, 2023
Platinum-based cancer drug compositions is a key innovation area in chemotherapy Platinum-based drugs are chemotherapeutic agents used for the treatment of cancer. These compounds cause their therapeutic effect by inhibiting DNA synthesis.
Pharmaceutical Technology
MARCH 14, 2023
According to GlobalData’s Technology Foresights, which uses over 756,000 patents to analyse innovation intensity for the pharmaceutical industry, there are 110 innovation areas that will shape the future of the industry. Among its key functions, it interacts with nucleic acids and enzymes during their synthesis and function.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
FEBRUARY 24, 2023
ACD-440 overview ACD-440 is under development for the treatment of neuropathic pain including painful peripheral polyneuropathy, peripheral mononeuropathy, postherpetic neuralgia (PHN), chemotherapy induced neuropathic pain, nerve injury pain, chronic postoperative neuropathic pain and peripheral neuropathic pain.
Roots Analysis
OCTOBER 24, 2023
Further, they are stable compounds and are retained ( in their active form ) within the body for longer durations, thereby decreasing the frequency of their administration. Hence, they are commonly used in the treatment of cancer, as part of the chemotherapy regime. They have the ability to prevent rapid growth and division of cells.
Pharmaceutical Technology
JULY 23, 2008
The world’s biggest pharmaceutical company Pfizer announced in June 2008 that it would be putting its “full scope and scale” behind a push into the cancer market. “Companies used to be universally protected by patents but there is a pathway to approval opening up for biosimilar legislation. .
Expert insights. Personalized for you.
52 
Let's personalize your content